Clinical Technology Act Advnc - MI Wayne, Livonia 48152

Clinical Technology Act Advnc entered the industry of Research and Development Laboratories in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 8112191, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.

To acquire more information, please contact by calling (313) 592-8476 during business hours. You can also write to the business’ Single Location at 18241 Pershing St, Livonia, Michigan MI 48152. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Clinical Technology Act Advnc
Place of Business: 18241 Pershing St, Livonia, MI 48152
Contact Number: (313) 592-8476
Type of Service: Research and Development Laboratories
SIC Number: 8731
NAICS Number: 8112191
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Clinical Technology Act Advnc is a company operating from Wayne, Michigan providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 8112191 as Research and Development Laboratories.

With a current employee count of 1 to 4, Clinical Technology Act Advnc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative at (313) 592-8476 for related queries, or to locate its Single Location using the coordinates 42.420691,-83.317744.

The Single Location can also be found at the street address 18241 Pershing St in Livonia, Michigan 48152 and can be engaged online through the company website at , the company Twitter , and Facebook page .